BNGO News and Press, Bionano Genomics Inc. From 11/03/22

Bionano Genomics press release ( NASDAQ: BNGO ): Q3 net loss of $31.81M. Revenue of $7.22M (+54.9% Y/Y) beats by $0.43M . Grew the installed base of Saphyr systems from 196 at the end of Q2 2022 by 21 to 217 as of the end of Q3 2022, an 11% increase compared to Q2 ...

–  55% year-over-year revenue growth in Q3 2022 –  On track to achieve all 2022 ELEVATE! milestones –  Strong balance sheet with $180.2 million in cash, cash equivalents, and available-for-sale securities at the end of Q3 2022 &#...

SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the first published validation study to evaluate the performance of optical genome mapping (OGM) versus traditional cytogenetic techniques for the analysis of hematological neoplasms. Accordin...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s true that the troika of Microsoft (NASDAQ: MSFT ), Alphabet (NASDAQ: GOOG , NASDAQ: GOOGL ), and Meta (NASDAQ: META ), much loved by the Street for the decade that ended in mid-2021, report...

Dr. Alka Chaubey, chief medical officer at Bionano, Dr. Nikhil Sahajpal, Greenwood Genetic Center, Dr. Rashmi Kanagal-Shamanna , MD Anderson Cancer Center, and Dr. Adam Smith , University Health Network will host a sponsored vendor presentation on s...

SAN DIEGO, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced that it will host a conference call and live webcast on Thursday, November 3, 2022 at 4:30 p.m. Eastern Time to report financial results for the third quarter 2022 and to high...

Shares of Bionano Genomics (NASDAQ: BNGO) tumbled by more than 55% this year, but that hasn't led Wall Street analysts who follow the stock to walk back their year-ahead price estimates or change their recommendations -- and for them, it's still a buy. In fact, compared to its c...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: CI Photos / Shutterstock.com ESSA Pharma (NASDAQ: EPIX ) stock is flying higher on Wednesday following the release of data from a Phase 1/2 study of EPI-7386 . EPI-7386 is a drug in development for th...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Dennis Diatel / Shutterstock.com Bionano Genomics (NASDAQ: BNGO ) stock is rising higher on Wednesday after providing an update on its Long String VANTAGE product. This is a system that handles ...

Bionano Genomics' ( NASDAQ: BNGO ) Long String VANTAGE, asystem for automated, high throughput isolation of ultra high molecular weight (UHMW) DNA for optical genome mapping (OGM), is now available . Bionano ( BNGO ) CEO Erik Holmlin said that UHMW DNA analysis "ca...